← back to search

Na Zhang

Shanghai Medical College of Fudan University · CN
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Radiation therapy, Breast cancer, Supraclavicular fossa, Axilla, and Radiation treatment planning.
h-index
—
citations
12
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
Radiation Oncology 2023cited by 1position: middledoi
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial
Practical Radiation Oncology 2022cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2022–2023)Lihua Dong · Jilin University2 papers (2022–2023)Lina Zhao · Jilin Normal University2 papers (2022–2023)— · 2 papers (2022–2023)Jing Jin · Soochow University2 papers (2022–2023)Xiaohong Wang · Chongqing University2 papers (2022–2023)Jian Tie · Ministry of Education2 papers (2022–2023)— · 2 papers (2022–2023)Weifang Yang · Wenzhou Medical University2 papers (2022–2023)Yuchun Song · East China University of Science and Technology2 papers (2022–2023)Yufei Lu · Fudan University2 papers (2022–2023)Hong-Fen Wu · Zhengzhou University2 papers (2022–2023)Ye‐Xiong Li · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2022–2023)Shulian Wang · South China Institute of Collaborative Innovation2 papers (2022–2023)Xiaorong Hou · Union Hospital2 papers (2022–2023)— · 2 papers (2022–2023)Jun Zhang · Anhui University of Technology1 papers (2023–2023)Jun Zhang · Hebei Medical University1 papers (2022–2022)Zhihui Hu · Pennsylvania State University1 papers (2023–2023)Jun Ma · Nanjing University of Chinese Medicine1 papers (2023–2023)